Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery

Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.

In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.

 

whitepaper image
download icon

Download whitepaper

Designing smarter trials: Precision medicine strategies for a new era of clinical research

Traditional approaches to clinical trials are often too rigid to be suitable in certain therapeutic areas. Accordingly, a new generation of clinical trials has evolved in precision medicine to account for the heterogeneity of diseases and individuals. This results in trials that are far more patient-centered and can prevent unnecessary burden on patients who may not be responsive to a specific treatment. Flexible trial designs can also help overcome common barriers to recruitment and improve overall feasibility.

This whitepaper outlines key design strategies that support precision medicine approaches, including the role of biomarkers, the adoption of master protocols (basket, umbrella, and platform trials), the innovation of n-of-1 trials, and the integration of real-world data into trials. 

Download now to learn more.

Group 5485-Jul-08-2025-04-13-32-2744-PM